Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A DNA strand, also called a polynucleotide chain, is a linear polymer composed of nucleotide monomers. Each nucleotide consists of a deoxyribose sugar, phosphate group, and one of four nitrogenous bases—adenine (A), cytosine (C), guanine (G), and thymine (T). The backbone is formed by alternating sugar and phosphate groups linked via phosphodiester bonds. Each strand has directionality defined by its chemical ends—5′ phosphate and 3′ hydroxyl. In cells, two complementary antiparallel strands form the iconic double helix structure stabilized by hydrogen bonding between paired bases. The sequence encodes genetic information essential for heredity and cellular function; it serves as both template for its own replication during cell division and for RNA synthesis during gene expression.
Intercalation between base pairs causing disruption of replication/transcription (e.g., doxorubicin); Alkylation/crosslinking of bases leading to strand breaks or mispairing (e.g., cisplatin, cyclophosphamide); Induction of single/double-strand breaks by free radicals or direct cleavage (e.g., bleomycin)
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA strand.